Livzon Pharmaceutical Group Inc. (Livzon Pharma) will convene its board of directors on 21 August 2026. The agenda includes consideration and approval of the unaudited interim financial results for the six months ended 30 June 2026, along with other corporate matters.

The meeting notification, dated 6 August 2026, was issued by Company Secretary Liu Ning from Zhuhai, China.

Board composition as of the notice date: • Executive Directors: President Liu Daping and Vice Chairman Tang Yanggang • Non-Executive Directors: Chairman Zhu Baoguo, Lin Nanqi and Qiu Qingfeng • Employee Representative Director: Ran Yongmei • Independent Non-Executive Directors: Luo Huiyuan, Cui Lijie, Wang Zhiyao and Kang Li

No further financial figures or operational details were provided in the announcement. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have disclaimed responsibility for the content’s accuracy or completeness.